News
Quilaban equips RISE-Health Biomarker Laboratory with sequencing and digital PCR technologies
Quilaban

The new biomedical research platform, based at the Faculty of Medicine of the University of Porto, features solutions from Illumina and QIAGEN, designed to support research and the development of new diagnostic approaches.
On 21 October, the Faculty of Medicine of the University of Porto (FMUP) and RISE-Health inaugurated the new Biomarker Laboratory, an infrastructure dedicated to biomedical research and the development of solutions for clinical practice. Quilaban helped equip the platform with next-generation sequencing and digital PCR technologies, through its partnerships with Illumina and QIAGEN.
Funded by Portugal’s Recovery and Resilience Plan (PRR) with an investment of around €2.1 million, the laboratory aims to accelerate research across several areas of health, with particular relevance to oncology and neurological and neurodegenerative diseases. Part of RISE-Health, a research unit based at FMUP, the platform is a shared resource that gives researchers in the network the tools to develop their projects.
The equipment supplied by Quilaban includes Illumina’s MiSeq i100 Plus and NextSeq 2000 sequencers and QIAGEN’s QIAcuity Dx system. These complementary technologies support genomic analysis and biomarker research, contributing to the development of new diagnostic approaches.
In addition to supplying the equipment, Quilaban also provided training for the teams who will use it. Pedro Pinto, of Quilaban, led the training on the two Illumina sequencers, while the QIAcuity Dx training was delivered by Ana Carvalho, of Quilaban, and Jamal Qualai, of QIAGEN.
The collaboration continues after installation, with Quilaban providing technical and scientific support to the laboratory teams as they use the technologies in their research projects.
Taking part in this project is a contribution to the advancement of biomedical research in Portugal and strengthens Quilaban’s collaboration with scientific institutions in providing technological solutions for research and diagnostics.
To learn more about the new Biomarker Laboratory and the technologies it houses, watch the RTP report here.